Tumor burden score predicted survival in patients with a performance status of 0; only a high TBS predicted survival with a PS of 1 or 2.

Recent novel treatments for chronic lymphocytic leukemia (CLL), such as second-generation covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax-obinutuzumab (VenO), may offer better ...

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years.

These results may help guide management strategies and prognostication among patients with advanced NSCLC who experience severe irAE and in whom permanent ICI discontinuation is required,” the ...

B-cell maturation antigen (BCMA)-directed bispecific antibodies have tolerable safety profiles in frail patients with relapsed/refractory multiple myeloma (MM), according to a real-world study ...

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.